Buzz Shock

Smooth icon storytelling with classy flair.

general

ENOB Enochian Biosciences Inc Compare

Written by John Shaw — 0 Views
Thursday, 10 August 2023

globenewswire

Renovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
Wednesday, 26 October 2022

wsj

Corrections & Amplifications
Monday, 24 October 2022

wsj

Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data
Tuesday, 20 July 2021

yahoo

Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer - Yahoo Finance
Monday, 12 July 2021

yahoo

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection - Yahoo Finance
Wednesday, 12 May 2021

yahoo

A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy
Thursday, 14 May 2020

zacks

Company News for May 14, 2020
Thursday, 23 April 2020

yahoo

Is Enochian Biosciences In A Good Position To Deliver On Growth Plans?
Monday, 6 January 2020

yahoo

Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the appointment of two board members:
Saturday, 26 October 2019

yahoo

We're Not Very Worried About Enochian Biosciences's Cash Burn Rate
Wednesday, 16 January 2019

yahoo

OTC Markets Group Announces Quarterly Index Performance and Rebalancing
Friday, 4 January 2019

yahoo

How Much Of Enochian Biosciences Inc. Do Insiders Own?
Wednesday, 5 December 2018

ptcommunity

Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”
Monday, 3 December 2018

streetinsider

Enochian Biosciences to Present at Biotech Showcase 2019